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Abstract. Objective: Adrenal failure, a treatable
condition, can have catastrophic consequences if un-
recognized in critically ill ED patients. The authors’
objective was to prospectively study adrenal function
in a case series of hemodynamically unstable (high-
risk) patients from a large, urban ED over a 12-
month period. Methods: In a prospective manner,
critically ill adult patients presenting to the ED were
enrolled when presenting with a mean arterial blood
pressure #60 mm Hg requiring vasopressor therapy
for more than one hour after receiving fluid resusci-
tation (central venous pressure of 12–15 mm Hg or a
minimum of 40 mL/kg of crystalloid). Patients were
excluded if presenting with hemorrhage, trauma, or
AIDS, or if steroids were used within the previous six
months. An adrenocorticotropic hormone (ACTH)
stimulation test was performed and serum cortisol
was measured. Treatment for adrenal insufficiency
was not instituted. Results: A total of 57 consecutive
patients were studied. Of these, eight (14%) had base-
line serum cortisol concentrations of <20 mg/dL (<552
nmol/L), which was considered adrenal insufficiency
(AI). Three additional patients (5%) had subnormal
60-minute post-ACTH-stimulation cortisol responses
(<30 mg/dL) and a delta cortisol #9 mg/dL, which is
the difference between the baseline and 60-minute
levels. This is functional hypoadrenalism (FH). There
were no laboratory abnormalities that distinguished
patients with AI or FH from those with preserved ad-
renal function (PAF). Rates of survival to discharge
did not differ between the AI group (7 of 8) and PAF
patients (21 of 46; p = 0.052). Conclusions: Adrenal
dysfunction is common in high-risk ED patients.
Overall, it has a frequency of 19% among a homoge-
neous population of hemodynamically unstable va-
sopressor-dependent patients. The effect of physio-
logic glucocorticoid replacement in this setting
remains to be determined. Key words: adrenal insuf-
ficiency; adrenal dysfunction; hypotension; shock;
emergency; functional hypoadrenalism; adrenal cri-
sis; hypoadrenalism. ACADEMIC EMERGENCY
MEDICINE 1999; 6:626–630
CORTISOL is a major stress response hor-mone that has metabolic, catabolic, anti-in-
flammatory, and vasoactive properties on cardiac
muscle and the peripheral vasculature. Cortisol
mediates maintenance of peripheral vasomotor
tone by facilitating catecholamine-induced vaso-
constriction and it has a permissive effect on syn-
thesis of catecholamines and vasoactive peptides.1,2
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In addition, cortisol has inotropic effects3 and
acutely influences fluid distribution, favoring ac-
cumulation in the vascular compartment.3
In response to external or internal stress, the
neuronally stimulated release of corticotropin-
releasing factor from the hypothalamus induces an
increase in adrenocorticotropic hormone (ACTH)
secretion by the anterior pituitary gland. This re-
sponse overrides the normal diurnal pattern of se-
cretion. The adrenal cortex responds to ACTH by
increasing cortisol secretion. Prolonged elevation
of serum cortisol triggers a negative feedback in-
hibition loop that results in subsequent decreases
in ACTH and cortisol release.4
Patients with normal hypothalamic–pituitary–
adrenal (HPA) axis function are consistently found
to have elevated circulating cortisol concentrations
during periods of stress or serious illness.5–8 Nu-
merous studies of HPA axis function in seriously
ill patients have shown that total serum cortisol is
increased, from two to ten times the upper limit of
normal.9–12 While the general incidence of overt ad-
renal insufficiency is extremely low,13 occult or un-
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TABLE 1. Serum Cortisol Concentrations and Adrenocorticotropic Hormone (ACTH) Stimulation Test
Adrenal Functional Status n (%)
Serum Cortisol (mg/dL) 6 SD
Baseline 60 Min Delta
Adrenal insufficiency 8 (14%) 16.0 6 3.9 34.4 6 10.2 17.3 6 10.7
Functional hypoadrenalism 3 (5%) 24.8 6 4.2 27.6 6 1.5 2.80 6 3.4
Preserved adrenal function 46 (81%) 68.8 6 63.4 76.7 6 55.5 9.4 6 18.3
recognized adrenal dysfunction (AD) has a high
prevalence among seriously ill patients.14,15
The purpose of this study was to examine the
incidence of adrenal hypofunction in hemodynam-
ically unstable (high-risk) patients presenting di-
rectly to the ED.
METHODS
Study Design. This was a prospective evaluation
of adrenal function in critically ill hypotension ED
patients. This study was approved by the Henry
Ford Hospital Institutional Review Board (IRB) for
Human Research in 1994, with waiver of consent.
The committee believed that the clinical indication
for assessing adrenal function in critically ill pa-
tients was no inordinate risk, but rather, a stan-
dard of care, although it had been understudied in
this environment. Furthermore, cortisol levels
were available to treating clinicians to guide sub-
sequent patient management. The project was not
begun until 1995 because of funding issues. The
IRB renewed approval in 1995.
Study Setting and Population. For a 12-month
period (October 1, 1995, to October 1, 1996), adult
patients presenting in shock to the ED who re-
quired vasopressor therapy after adequate fluid re-
suscitation were entered into the study. Hypoten-
sion or shock was defined as mean arterial blood
pressure # 60 mm Hg. Adequate fluid resuscita-
tion was defined as a central venous pressure
(CVP) of 12–15 mm Hg or consisting of a minimum
replacement of 40 mL/kg of volume resuscitation.
Patients were excluded if they reported steroid use
within six months, hemorrhage, trauma, or AIDS.
Study Protocol. The patients were managed
solely by the emergency physicians. After baseline
laboratory tests were obtained, the ACTH stimu-
lation test was performed. Baseline cortisol and
ACTH levels were obtained and synthetic ACTH
0.25 mg (Cortrosyn, Organon, NJ) was adminis-
tered IV over 2 minutes; subsequent cortisol levels
were obtained at 30 and 60 minutes postinjection.
In normal subjects, cortisol concentrations
range from 5 to 20 mg/dL (138 to 552 nmol/L), being
higher at 7 to 9 AM; plasma ACTH has a normal
range from 10 to 130 pg/mL (2 to 29 pmol/L). The
response to ACTH stimulation in healthy subjects
is defined as an increase of 50% or more in serum
cortisol concentration, or of at least 9 mg/dL, by 60
minutes posts-ACTH injection of cosyntropin.
However, in critically ill patients, adrenal dysfunc-
tion has been defined as the presence of random
serum cortisol <20 mg/dL (<552 nmol/L).16–21 An ad-
ditional category, functional hypoadrenalism (FH),
has been defined as the combination of random se-
rum cortisol $20 mg/dL, and a serum cortisol level
at 60 minutes post-ACTH stimulation of <30 mg/
dL or delta cortisol (60-minute level minus base-
line) of #9 mg/dL.22–25
Blood for cortisol measurement was collected in
glass tubes; the serum was separated and stored
at 2207C until assayed. A commercial radioim-
munoassay (RIA) kit was used for the quantitative
measurement of cortisol in serum (Amerlex Corti-
sol RIA Kit, Amersham, Arlington Heights, IL).
Blood for ACTH measurement was collected in sil-
iconized glass ethylenediamine tetraacetic acid
(EDTA) tubes. The plasma was separated and
transferred into polypropylene tubes and frozen for
storage within 15 minutes, and stored at 2707C
until assayed. A commercially available immuno-
assay was used for the quantitative determination
of ACTH in plasma (Allegro HS-ACTH, Nichols In-
stitute, San Juan Capistrano, CA).
Data Analysis. All results are reported as the
mean and the standard deviation. Analysis of var-
iance (ANOVA) was used with Tukey’s method of
multiple comparisons. The Kruskal-Wallis test and
the Wilcoxon nonparametric test were used to
identify differences in the ranks of data between
the three groups studied. Statistical significance
was defined by a p-value less than 0.05 and an al-
pha-level of 0.017.
RESULTS
A total of 68 consecutive patients were originally
enrolled: 11 of them were subsequently excluded
because they did not meet the inclusion criteria.
Of the 57 patients, eight (14%) had a baseline cor-
tisol less than 20 mg/dL and these patients were
therefore classified as adrenal insufficient (AI). Of
the 49 patients with a baseline cortisol of $20 mg/
dL, an additional group of three patients (5%) had
a post-ACTH cortisol level <30 mg/dL, demonstrat-
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TABLE 2. Baseline Adrenocorticotropic Hormone (ACTH)
Concentrations (pg/mL) 6 SD












*AI = adrenal insufficiency; FH = functional hypoadrenalism;
PAF = preserved adrenal function.
†Normal range for ACTH in nonstressed healthy subjects is
10–130 pg/mL.
TABLE 3. Demographics
Adrenal Functional Status n
Gender
Female Male Age (Years) 6 SD
Adrenal insufficiency 8 3 (38%) 5 (62%) 55 6 4
Functional hypoadrenalism 3 0 (0%) 3 (100%) 68 6 15
Preserved adrenal function 46 25 (54%) 21 (46%) 72 6 12
ing functional hypoadrenalism (FH). The remain-
ing 46 patients had a baseline cortisol of >20 mg/
dL and a post-ACTH level of >9 mg/dL, thus dem-
onstrating preserved adrenal function (PAF) in
response to critical illness. These results are listed
in Table 1. ACTH concentrations were determined
for 43 of 57 patients and the results are listed in
Table 2. In the AI and PAF patients, the mean
ACTH levels were 13.5 and 99.5 pg/mL, respec-
tively. In the patient with FH, plasma ACTH was
205 pg/mL (Table 2).
There was no difference in gender distribution
between AI and PAF, while all three patients with
FH were male. In addition, the group with PAF
was slightly but significantly older than the AI
group (p < 0.004; Table 3). There was no significant
difference between groups in vital signs (Table 4)
or in baseline laboratory test values (Table 5). Sur-
vival data showed a high mortality overall (51%,
Table 6). There was no significant difference in
mortality between the AI and PAF patients (p =
0.052).
DISCUSSION
Adrenal insufficiency occurs with a high incidence
in the critically ill patient population. In both med-
ical and surgical critical care units, the respective
incidences of AI are markedly increased, ranging
from <0.01% to 20%5,26 and <2% to 27%,19 respec-
tively; whereas the incidence in the general popu-
lation is approximately 0.005%.13
Laboratory tests allow further categorization of
AD in the setting of critical illness. First, the clas-
sically described AI marked by persistent subnor-
mal cortisol production from the adrenal gland;
and second, the entity of FH, which manifests dur-
ing stressful conditions with inadequate cortisol
production (although within the normal or at the
upper limit for the unstressed state). Thus, pa-
tients with FH are characterized by inability to re-
spond with cortisol increases that would be appro-
priate for the clinical setting. In general, critically
ill patients do respond with appropriate elevation
in response to ACTH stimulation despite increased
basal cortisol levels.5,6,11 Furthermore, patients
with serum cortisol levels much higher than nor-
mal may still respond to steroid replacement ther-
apy with improved survival.6,15 Therefore, patients
with severe illnesses who are unable to attain su-
pranormal cortisol levels are thought to be at
higher risk for the development of complications.25
In fact, it has been suggested that relative AI may
be a contributing factor in poor outcomes in the
setting of severe illness.5,12,15,24,25
The clinical presentation of the ‘‘high-risk’’ AI is
one who has been adequately fluid resuscitated
with persistent hypotension often necessitating va-
sopressors for hemodynamic support.27 Besides hy-
potension and decreased cardiac output, some pa-
tients with AI may present with a septic
appearance (high-output circulatory failure, fever,
and mental status changes), although they are
abacteremic.3,7,15,18 Adding further complexity is the
absence of laboratory abnormalities and physical
findings that are characteristic of adrenal failure
(i.e., hyponatremia, hyperkalemia, and cutaneous
hyperpigmentation) in the early course of these
critically ill patients.3,5,7,15,28 There is therefore a
need for early recognition of hypotensive patients
who may be experiencing AI, as it is relatively easy
to diagnose and treat while a potential cause of
mortality.12
A large proportion of patients experiencing ex-
treme hypotension or acute shock syndrome, pres-
ent initially to the ED. Cortisol is needed for effec-
tive endogenous catecholamine pressor action; we
hypothesized that a subset of patients who are in
shock and require vasopressor support may have
occult adrenal failure not previously identified.
That was indeed the case in 14% of our patients.
Our study also found a small group of patients
with FH, who had adequate initial cortisol levels,
subnormal response to ACTH, and a mortality rate
of 66% (2 of 3). Rothwell et al.,25 who evaluated a
group of 32 patients in septic shock and adequate
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Blood Pressure (mm Hg)
Systolic Diastolic MAP*
Adrenal insufficiency 36.5 6 2.1 107 6 25 76 6 11 43 6 19 54 6 16
Functional hypoadrenalism 35.8 6 2.0 83 6 38 70 6 17 30 6 26 43 6 22
Preserved adrenal function 35.6 6 2.9 101 6 27 78 6 21 37 6 20 51 6 19
p-value — 0.404 0.811 0.608 0.701
*MAP = mean arterial pressure.
TABLE 5. Baseline Laboratory Tests: Mean 6 SD
Laboratory Test
Adrenal Functional Status*
AI FH PAF p-value
Sodium (mEq/L) 135 6 6 141 6 12 142 6 10 0.254
Potassium (mEq/L) 4.6 6 1.2 3.3 6 0.7 4.6 6 1.4 0.27
Bicarbonate (mmol/L) 15 6 6 16 6 11 18 6 8 0.69
Glucose (mg/dL) 194 6 224 127 6 69 206 6 272 0.384
Calcium (mg/dL) 8.1 6 1.5 7.8 6 1.3 8.5 6 1.0 0.533
Magnesium (mg/dL) 1.6 6 0.3 1.3 6 0.3 2.1 6 0.8 0.047
BUN (mg/dL) 47 6 38 50 6 47 52 6 40 0.949
Creatinine (mg/dL) 2.8 6 2 3.8 6 2.4 2.5 6 1.5 0.408
Hemoglobin (g/dL) 10.7 6 3.1 11.2 6 5.8 11.8 6 3.3 0.681
WBC count (thousand/mm3) 8.2 6 2.9 4.9 6 0.3 13.3 6 5.9 —
Eosinophils (no./mm3) 0.60 6 1.34 0 0.38 6 1.39 —
Lactate (mM/L) 2.4 6 2.3 7.5 6 5.4 5.6 6 4.6 0.14
pH (units) 7.25 6 0.19 7.16 6 0.42 7.3 6 0.22 0.563
*AI = adrenal insufficiency; FH = functional hypoadrenalism; PAF = preserved adrenal function.
TABLE 6. Outcome




AI 8 7 (86%)
FH 3 1 (33%)
PAF 46 21 (46%)
TOTAL 57 29 (51%)
*AI = adrenal insufficiency; FH = functional hypoadrenalism;
PAF = preserved adrenal function.
basal cortisol concentrations, found that 13 had a
defective response to ACTH stimulation and fatal
outcome (100%). By comparison, of the 19 remain-
ing patients with normal ACTH responses, only six
(32%) died. Moran et al.24 also noted a positive cor-
relation between decreased response to the ACTH
stimulation and increased mortality; moreover, pa-
tients had a low probability of responsiveness to
ACTH within the 24 hours preceding their deaths.
Nevertheless, several studies have reported a high
mortality associated with high cortisol levels
thought to be a function of the underlying severe
illness.5,6,10,11,20,24 In this study, mortality rate was
also extremely high among the patients with PAF.
In a recent study of cortisol kinetics during and
after cardiopulmonary arrest in the ED, it was
noted that failure to attain a cortisol level of at
least 30 mg/dL was associated with 100% mortality
at 24 hours.28
The pathogenesis of AD in this setting contin-
ues to evolve. Plasma ACTH levels, which were at
the low end of normal in the AI group, may reflect
hypothalamic–pituitary axis suppression. The el-
evated levels in the patient with FH may, however,
represent true adrenal failure. The pathogenesis of
AD in the setting of shock may include decreased
adrenal blood flow leading to primary adrenal fail-
ure. Inflammatory mediators may also cause pri-
mary adrenal failure through impairing cortisol re-
ceptors in the adrenal gland. These mediators have
also been shown to decrease corticotropin-releas-
ing hormone secretion leading to hypothalamic–
pituitary axis suppression or secondary adrenal
dysfunction.24,29,30 AD associated with septic shock
has been described as transient,30 with recovery oc-
curring after resolution of the inflammatory in-
sult.31
LIMITATION AND FUTURE QUESTIONS
A limitation in this study is the inability to pre-
cisely define and control for the duration of hypo-
tension before presentation to the ED, although
our sample size is comparable to other investiga-
tions of adrenal function in the critically ill. We
also did not control for those patients who subse-
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quently received replacement glucocorticoids in
the intensive care unit. Outcome-based evidence
for treatment recommendations cannot be made
because of the study design, however, hemody-
namic improvement and decreased vasopressor re-
quirements have been reported with physiologic
replacement doses of glucocorticoids.30,32,33
CONCLUSION
Nineteen percent of the hemodynamically unstable
patients who still require vasopressor therapy af-
ter adequate volume resuscitation have adrenal in-
sufficiency (adrenal dysfunction). This result is
consistent with the findings in similar populations
of high-risk intensive care unit patients. The effect
of diagnostic and therapeutic interventions on out-
come remains to be determined.
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